tradingkey.logo
tradingkey.logo
Search

C4 Therapeutics Inc

CCCC
Add to Watchlist
3.480USD
-0.180-4.92%
Close 07-31 16:00ETQuotes delayed by 15 min
384.77MMarket Cap
LossP/E TTM

Institutional Confidence

Currency: USD Updated: 2026-07-31
Previous score
5.00
Change
0
The current institutional shareholding score of C4 Therapeutics Inc is 5.00, ranking 132 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 69.01%, representing a quarter-over-quarter decrease of 2.67%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 2.52% of shares outstanding, with 13.18% increase in holdings.

Institutional Shareholding

Shareholder Activity

Name
Shares Held
Chg %
Point72 Asset Management, L.P.
Star Investors
9.44M
+11.34%
Morgan Stanley & Co. LLC
8.96M
+84.18%
RA Capital Management, LP
8.00M
--
Lynx1 Capital Advisors LLC
7.10M
--
Soleus Capital Management, L.P.
3.80M
-46.07%
Bain Capital Life Sciences Investors, LLC
3.13M
+55.05%
Wasatch Global Investors Inc
Star Investors
4.34M
-10.46%
Two Sigma Investments, LP
2.58M
+61.33%
BofA Global Research (US)
2.39M
+16.29%
1
2
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.